InMed Pharmaceuticals, Inc.

Ordinary Shares International Reporting
Verified Company Profile 6/28/2017
Contact Info
  • 340-200 Granville Street
  • Vancouver, BC V6C1S4
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: Canadian Securities Exchange
Audited Financials Audited
Latest Report Jun 30, 2017 Annual Report
CIK 0001429816
Fiscal Year End 6/30
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: British Columbia, Canada
Year of Inc. Not Available
Employees Not Available
Company Officers/Contacts
Eric A. Adams CEO
Jeff Charpentier CFO
Sazzad Hossain Chief Scientific Officer
Company Directors
Martin Bott
Adam Cutler
William Garner
Andrew Hull
Company Notes
  • Formerly=Cannabis Technologies Inc. until 10-2014
  • Formerly=Meridex Software Corp. until 5-2014
  • Formerly=Meridex Network Corp. until 2-03
Service Providers
Accounting/Auditing Firm
KPMG Accountants N.V.
4200 Wells Fargo Center
90 S. 7th St.
Minneapolis, MN, 55402
United States

Legal Counsel
Farris Vaughan Wills & Murphy LLP
25 Floor, 700 West Georgia Street
PO Box 10026
Pacific Centre South
Vancouver, BC, V7Y 1B3

Investor Relations Firm
Not Available
IMLFF Security Details
Share Structure
Market Value1 $71,902,448 a/o Nov 17, 2017
Authorized Shares Unlimited a/o Sep 15, 2017
Outstanding Shares 131,689,466 a/o Oct 11, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
Shareholders of Record 112 a/o Oct 25, 2016
Non US Stock Exchange Listing
IN - Canadian Securities Exchange - Qualified
Short Selling Data
Short Interest 18,723 (264.76%)
Oct 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security